ZettaCore was formed to develop molecular storage products. The company has licensed its technology from NCSU and the University of California at Riverside. ZettaCore has received two federal grants worth $2.4 million and is being incubated by Clinical Micro Sensors (CMS), a biochip company that was recently acquired by Motorola. However, Motorola/CMS has no equity interest in ZettaCore and never has. Zettacore should have closed its first round of funding by the time you read this.

David Bocian, Werner Kuhr and Dr. Jonathan Lindsey have developed a new molecular electronics technology that utilizes thiol-derivatized porphyrins for memory storage and has the potential to increase speed by a factor of 100 while reducing power consumption by a factor of five compared to silicon devices. The technology is patented by UCR and North Carolina State and is exclusively licensed by ZettaCore.

ZettaCore’s molecular devices, called porphyrins, are designed to register the removal of electrons. Instead of just reading two states, on and off, ZettaCores molecular storage devices can read four states – neutral, one lost electron, two lost electrons and three lost electrons – depending on the voltage level applied. Stay tuned…

Randy Levine, President & CEO

Jonathan Lindsey, Ph.D., Co-founder (chemistry professor at North Carolina State University)